NCT02732054
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Maharaj Nakorn Chiang Mai Hospital, Department of Medicine, Chiang Mai University Muang, Chiang Mai, Thailand
Clinical trial condition
Hepatitis B
Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.
458 public trials
28 recruiting studies
Hepatitis B trial results
Completed
Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)
NCT00440531
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT00393523
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT00106964
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +19 more
- Locations
-
- Childrens Hosp of Los Angeles Los Angeles, California, United States
- University of California at San Francisco San Francisco, California, United States
- Children's Hosp Natinal Med Center Washington D.C., District of Columbia, United States
- Tulane Med Center New Orleans, Louisiana, United States
NCT00107042
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- University of California at San Diego San Diego, California, United States
- University of California at San Francisco San Francisco, California, United States
- Children's Hospital National Medical Center Washington D.C., District of Columbia, United States
NCT02186977
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Centre for the Evaluation of Vaccination Vaccine & Infectious Disease Institute Wilrijk, Antwerp, Belgium
NCT00383591
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Hradec Králové, Czechia
- GSK Investigational Site Bandar Tun Razak, Cheras, Malaysia
- GSK Investigational Site Barcelona, Spain
- GSK Investigational Site Madrid, Spain
NCT00322361
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +18 more
- Locations
-
Not specified
NCT00603252
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- GSK Investigational Site Wilrijk, Belgium
- GSK Investigational Site Finsterwalde, Brandenburg, Germany
- GSK Investigational Site Dresden, Saxony, Germany
- GSK Investigational Site Geringswalde, Saxony, Germany
NCT00142740
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +19 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- University of California at San Francisco San Franciso, California, United States
- Children's Hospital National Medical Center Washington D.C., District of Columbia, United States
- University of Southern Florida College of Medicine Tampa, Florida, United States